Release Date: 26/02/16 13:55 Summary: December 2015 Half Yearly Financial Statements Price Sensitive: No Download Document 259.93KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%